605 results on '"Parks, S"'
Search Results
202. Untitled.
- Author
-
PARKS, S. W.
- Published
- 1837
203. Obituaries.
- Author
-
PARKS, S.
- Published
- 1853
204. Special Notices.
- Author
-
WHITEMAN, JOHN, BOWEN, J. E., PARKS, S., BEACH, J. W., NELSON, R., WALKER, JASON F., WOODWARD, THOS., and BROWER, CHAS. L.
- Published
- 1853
205. TROY CONFERENCE.
- Author
-
PARKS, S.
- Published
- 1852
206. MINUTES OF TROY CONFERENCE AGAIN.
- Author
-
PARKS, S.
- Published
- 1850
207. LANSINGBURGH, TROY CON.
- Author
-
PARKS, S.
- Published
- 1850
208. SPECIAL NOTICES.
- Author
-
PARKS, S., C, and DEVOL
- Published
- 1850
209. TROY DISTRICT PREACHERS' ASSOCIATION---BISHOP JANES' VISIT.
- Author
-
DEVOL, C. and PARKS, S.
- Published
- 1850
210. UNTITLED.
- Author
-
PARKS, S. L.
- Published
- 1873
211. Pilot report: AFTI (Advanced Fighter Technology Integration) F-111
- Author
-
Parks, Scott E., Maj
- Subjects
AIRCRAFT, EXPERIMENTAL ,AIRPLANE TYPE - F-111 ,AIRPLANES, MILITARY - Design ,AIRPLANES, MILITARY - Wings - Abstract
illus
- Published
- 1988
212. Now that's Americana!
- Author
-
Parks, S.
- Subjects
- *
COUNTRY music festivals - Abstract
The article discusses the 2011 annual Americana Music Festival and Awards held in Nashville, Tennessee, which include performances by keyboardist Ian McLagan, John Oates and soul singer Bekka Bramlett.
- Published
- 2012
213. AND WE LOVE HIM.
- Author
-
PARKS, S.
- Subjects
- *
CONCERTS , *ROCK musicians - Abstract
The article reviews a concert by Paul McCartney in Nashville, Tennessee.
- Published
- 2010
214. Tin Pan Alley--New York to Nashville.
- Author
-
Parks, S.
- Subjects
- *
MUSICAL performance , *MUSIC festivals - Abstract
The article reviews several performances at the Tin Pan South festival in Nashville, Tennessee in 2011 including those by Doug Johnson, Amy Grant and Bo Bice.
- Published
- 2011
215. FINANCIAL COMMITTEE.
- Author
-
PARKS, S. P.
- Published
- 1886
216. In-Plate Cryopreservation of 2D and 3D Cell Models: Innovative Tools for Biomedical Research and Preclinical Drug Discovery
- Author
-
Marie-Ann Ewart, Colin J. Wilde, Alessandra Prinelli, Catarina Silva-Almeida, Erin Sutherland, Anna Pasotti, Aikaterini Telopoulou, Sophie Dunlop, Elfi Töpfer, Martin Lynch, Sisely Parks, Prinelli A., Silva-Almeida C., Parks S., Pasotti A., Telopoulou A., Dunlop S., Sutherland E., Lynch M., Ewart M.-A., Wilde C.J., and Topfer E.
- Subjects
0301 basic medicine ,Cell physiology ,3D culture ,Biomedical Research ,Computer science ,organoid ,Cell ,cell-based assay ,Cell Culture Techniques ,Drug Evaluation, Preclinical ,Computational biology ,Biochemistry ,Cryopreservation ,Analytical Chemistry ,03 medical and health sciences ,0302 clinical medicine ,Drug Discovery ,medicine ,Humans ,Viability assay ,Primary cell ,multiwell platform ,Drug discovery ,Mesenchymal stem cell ,030104 developmental biology ,medicine.anatomical_structure ,Cell culture ,in-plate cryopreservation ,Molecular Medicine ,030217 neurology & neurosurgery ,Biotechnology - Abstract
Cell-based assays performed in multiwell plates are utilized in basic and translational research in a variety of cell models. The assembly of these multiwell platforms and their use is often laboratory specific, preventing the standardization of methods and the comparison of outputs across different analytical sites. Moreover, when cell models are based on primary cells with specialized culture requirements, including three-dimensional (3D) cell culture, their complexity and the need for manipulation by experienced operators can add significant cost and introduce long lead times to analysis, both of which are undesirable in any preclinical situation. To address this issue, we explored adaptations of cryopreservation technology that allow cells to be cryopreserved in-plate, ready for use in analysis, and have developed a method applicable to cells from different origins and different culture formats. Here we describe the application of this technology to conventional two-dimensional (2D) monolayers of human mesenchymal stem cells (MSCs) and human macrophages derived from primary monocytes, and to 3D cultures of hepatic organoids, colon organoids, and colon tumor organoids, each presented for cryopreservation in their obligate extracellular matrix. We demonstrated that cell viability, cell physiology, and cytotoxic sensitivity were maintained after cryopreservation, such that the models offer the means to uncouple model assembly from analytical use and to standardize cell models in product form for distribution to end users.
- Published
- 2020
217. Electric field sensor studies
- Author
-
Parks, S.
- Published
- 1977
218. Reservoir delineation using 3-D seismic: Stevens sands, southern San Joaquin basin, California
- Author
-
Parks, S [ARCO Oil and Gas Co., Bakersfield, CA (USA)]
- Published
- 1990
219. Use of complementary medicine by adult patients participating in cancer clinical trials [corrected] [published erratum appears in ONCOL NURS FORUM 2000 Jul; 27(6): 888].
- Author
-
Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, Steinberg SM, and Wootton J
- Abstract
PURPOSE/OBJECTIVES: To document the prevalence, demographic correlates, patterns of use, and beliefs about complementary and alternative medicine (CAM) therapies of adult patients enrolled in National Cancer Institute (NCI) clinical trials. DESIGN: Prospective, cross-sectional, descriptive survey. SETTING: W.G. Magnuson Clinical Center of the National Institutes of Health in Bethesda, MD. SAMPLE: Convenience sample of 100 English-speaking, adult patients with cancer admitted to intramural clinical trials. METHODS: A standardized, 99-item questionnaire assessing use of CAM therapies pre- and postcancer diagnosis was administered by face-to-face interview. MAIN RESEARCH VARIABLES: Use of CAM therapies, beliefs, communication with physician. FINDINGS: 63% used at least one CAM therapy, with an average use of two therapies per patient. Men were significantly less likely to use a therapy than women; women were more likely to use numerous therapies. Cancer diagnosis seems to have had no influence overall on the frequency of use of CAM therapies. The major reasons stated for CAM use were for treatment-related medical conditions as well as depression, anxiety, and insomnia. The most frequently reported therapies were spiritual, relaxation, imagery, exercise, lifestyle diet (e.g., macrobiotic, vegetarian), and nutritional supplementation. Patients unanimously believed that these complementary therapies helped to improve their quality of life through more effective coping with stress, decreasing the discomforts of treatment and illness, and giving them a sense of control. CONCLUSIONS: Patients with cancer use various complementary therapies to cope with their disease and the rigors of clinical trials. Women and those with higher educational backgrounds were more frequent users. IMPLICATIONS FOR NURSING PRACTICE: Nurses who provide care to subjects of biomedical research have an opportunity and responsibility regarding their patients' use of CAM therapies. Nurses may use in-house resources to help evaluate subjects' use of a CAM modality or to provide quality-of-life therapies such as relaxation, imagery, or healing touch. Discussing these health practices in a nonjudgmental manner adds to the assessment of patients' coping skills and ability to make decisions about their health care. [ABSTRACT FROM AUTHOR]
- Published
- 2000
220. P 431 Title: An objective method of assessing photoreceptor function in retinal detachment surgery
- Author
-
Keating, D., Parks, S., Williamson, T.H., and Hammer, H.H.
- Published
- 1995
- Full Text
- View/download PDF
221. P 432 Title: The response topography of ERG B-wave amplitude densities with eccentricity using the M-sequence-stimulation-technique
- Author
-
Parks, S., Keating, D., Williamson, T.H., Evans, A.L., Elliott, A.T., and Jay, J.L.
- Published
- 1995
- Full Text
- View/download PDF
222. Search for new particles leading to Z plus jets final states in p(p)over-bar collisions at root s=1.96 TeV
- Author
-
Aaltonen, T., Abulencia, A., Adelman, J., Affolder, T., Akimoto, T., Albrow, M. G., Amerio, S., Amidei, D., Anastassov, A., Anikeev, K., Annovi, A., Antos, J., Aoki, M., Apollinari, G., Arisawa, T., Artikov, A., Ashmanskas, W., Attal, A., Aurisano, A., Azfar, F., Azzi-Bacchetta, P., Azzurri, P., Bacchetta, N., Badgett, W., Barbaro-Galtieri, A., Barnes, V. E., Barnett, B. A., Baroiant, S., Bartsch, V., Bauer, G., Beauchemin, P. -H., Bedeschi, F., Behari, S., Bellettini, G., Bellinger, J., Belloni, A., Benjamin, D., Beretvas, A., Beringer, J., Berry, T., Bhatti, A., Binkley, M., Bisello, D., Bizjak, I., Blair, R. E., Blocker, C., Blumenfeld, B., Bocci, A., Bodek, A., Boisvert, V., Bolla, G., Bolshov, A., Bortoletto, D., Boudreau, J., Boveia, A., Brau, B., Brigliadori, L., Bromberg, C., Brubaker, E., Budagov, J., Budd, H. S., Budd, S., Burkett, K., Busetto, G., Bussey, P., Buzatu, A., Byrum, K. L., Cabrera, S., Campanelli, M., Campbell, M., Canelli, F., Canepa, A., Carrillo, S., Carlsmith, D., Carosi, R., Carron, S., Casal, B., Casarsa, M., Castro, A., Catastini, P., Cauz, D., Cavalli-Sforza, M., Cerri, A., Cerrito, L., Chang, S. H., Chen, Y. C., Chertok, M., Chiarelli, G., Chlachidze, G., Chlebana, F., Cho, I., Cho, K., Chokheli, D., Chou, J. P., Choudalakis, G., Chuang, S. H., Chung, K., Chung, W. H., Chung, Y. S., Cilijak, M., Ciobanu, C. I., Ciocci, M. A., Clark, A., Clark, D., Coca, M., Compostella, G., Convery, M. E., Conway, J., Cooper, B., Copic, K., Cordelli, M., Cortiana, G., Crescioli, F., Almenar, C. C., Cuevas, J., Culbertson, R., Cully, J. C., Daronco, S., Datta, M., D'Auria, S., Davies, T., Dagenhart, D., De Barbaro, P., De Cecco, S., Deisher, A., De Lentdecker, G., De Lorenzo, G., Dell'Orso, M., Delli Paoli, F., Demortier, L., Deng, J., Deninno, M., De Pedis, D., Derwent, P. F., Di Giovanni, G. P., Dionisi, C., Di Ruzza, B., Dittmann, J. R., D'Onofrio, M., Dörr, C., Donati, S., Dong, P., Donini, J., Dorigo, T., Dube, S., Efron, J., Erbacher, R., Errede, D., Errede, S., Eusebi, R., Fang, H. C., Farrington, S., Fedorko, I., Fedorko, W. T., Feild, R. G., Feindt, M., Fernandez, J. P., Field, R., Flanagan, G., Forrest, R., Forrester, S., Franklin, M., Freeman, J. C., Furic, I., Gallinaro, M., Galyardt, J., Garcia, J. E., Garberson, F., Garfinkel, A. F., Gay, C., Gerberich, H., Gerdes, D., Giagu, S., Giannetti, P., Gibson, K., Gimmell, J. L., Ginsburg, C., Giokaris, N., Giordani, M., Giromini, P., Giunta, M., Giurgiu, G., Glagolev, V., Glenzinski, D., Gold, M., Goldschmidt, N., Goldstein, J., Golossanov, A., Gomez, G., Gomez-Ceballos, G., Goncharov, M., González, O., Gorelov, I., Goshaw, A. T., Goulianos, K., Gresele, A., Grinstein, S., Grosso-Pilcher, C., Group, R. C., Grundler, U., Guimaraes Da Costa, J., Gunay-Unalan, Z., Haber, C., Hahn, K., Hahn, S. R., Halkiadakis, E., Hamilton, A., Han, B. -Y., Han, J. Y., Handler, R., Happacher, F., Hara, K., Hare, D., Hare, M., Harper, S., Harr, R. F., Harris, R. M., Hartz, M., Hatakeyama, K., Hauser, J., Hays, C., Heck, M., Heijboer, A., Heinemann, B., Heinrich, J., Henderson, C., Herndon, M., Heuser, J., Hidas, D., Hill, C. S., Hirschbuehl, D., Hocker, A., Holloway, A., Hou, S., Houlden, M., Hsu, S. -C., Huffman, B. T., Hughes, R. E., Husemann, U., Huston, J., Incandela, J., Introzzi, G., Iori, M., Ivanov, A., Iyutin, B., James, E., Jang, D., Jayatilaka, B., Jeans, D., Jeon, E. J., Jindariani, S., Johnson, W., Jones, M., Joo, K. K., Jun, S. Y., Jung, J. E., Junk, T. R., Kamon, T., Karchin, P. E., Kato, Y., Kemp, Y., Kephart, R., Kerzel, U., Khotilovich, V., Kilminster, B., Kim, D. H., Kim, H. S., Kim, J. E., Kim, M. J., Kim, S. B., Kim, S. H., Kim, Y. K., Kimura, N., Kirsch, L., Klimenko, S., Klute, M., Knuteson, B., B. R., Ko, Kondo, K., Kong, D. J., Konigsberg, J., Korytov, A., Kotwal, A. V., Kraan, A. C., Kraus, J., Kreps, M., Kroll, J., Krumnack, N., Kruse, M., Krutelyov, V., Kubo, T., Kuhlmann, S. E., Kuhr, T., Kulkarni, N. P., Kusakabe, Y., Kwang, S., Laasanen, A. T., Lai, S., Lami, S., Lammel, S., Lancaster, M., Lander, R. L., Lannon, K., Lath, A., Latino, G., Lazzizzera, I., Lecompte, T., Lee, J., Lee, Y. J., Lee, S. W., Lefèvre, R., Leonardo, N., Leone, S., Levy, S., Lewis, J. D., Lin, C., Lin, C. S., Lindgren, M., Lipeles, E., Lister, A., Litvintsev, D. O., Liu, T., Lockyer, N. S., Loginov, A., Loreti, M., R. -S., Lu, Lucchesi, D., Lujan, P., Lukens, P., Lungu, G., Lyons, L., Lys, J., Lysak, R., Lytken, E., Mack, P., Macqueen, D., Madrak, R., Maeshima, K., Makhoul, K., Maki, T., Maksimovic, P., Malde, S., Malik, S., Manca, G., Manousakis, A., Margaroli, F., Marginean, R., Marino, C., Marino, C. P., Martin, A., Martin, M., Martin, V., Martínez, M., Martínez-Ballarín, R., Maruyama, T., Mastrandrea, P., Masubuchi, T., Matsunaga, H., Mattson, M. E., Mazini, R., Mazzanti, P., Mcfarland, K. S., Mcintyre, P., Mcnulty, R., Mehta, A., Mehtala, P., Menzemer, S., Menzione, A., Merkel, P., Mesropian, C., Messina, A., Miao, T., Miladinovic, N., Miles, J., Miller, R., Mills, C., Milnik, M., Mitra, A., Mitselmakher, G., Miyamoto, A., Moed, S., Moggi, N., Mohr, B., Moon, C. S., Moore, R., Morello, M., Movilla Fernandez, P., Mülmenstädt, J., Mukherjee, A., Muller, Th., Mumford, R., Murat, P., Mussini, M., Nachtman, J., Nagano, A., Naganoma, J., Nakamura, K., Nakano, I., Napier, A., Necula, V., Neu, C., Neubauer, M. S., Nielsen, J., Nodulman, L., Norniella, O., Nurse, E., S. H., Oh, Y. D., Oh, Oksuzian, I., Okusawa, T., Oldeman, R., Orava, R., Osterberg, K., Pagliarone, C., Palencia, E., Papadimitriou, V., Papaikonomou, A., Paramonov, A. A., Parks, B., Pashapour, S., Patrick, J., Pauletta, G., Paulini, M., Paus, C., Pellett, D. E., Penzo, A., Phillips, T. J., Piacentino, G., Piedra, J., Pinera, L., Pitts, K., Plager, C., Pondrom, L., Portell, X., Poukhov, O., Pounder, N., Prakoshyn, F., Pronko, A., Proudfoot, J., Ptohos, F., Punzi, G., Pursley, J., Rademacker, J., Rahaman, A., Ramakrishnan, V., Ranjan, N., Redondo, I., Reisert, B., Rekovic, V., Renton, P., Rescigno, M., Richter, S., Rimondi, F., Ristori, L., Robson, A., Rodrigo, T., Rogers, E., Rolli, S., Roser, R., Rossi, M., Rossin, R., Roy, P., Ruiz, A., Russ, J., Rusu, V., Saarikko, H., Safonov, A., Sakumoto, W. K., Salamanna, G., Saltó, O., Santi, L., Sarkar, S., Sartori, L., Sato, K., Savard, P., Savoy-Navarro, A., Scheidle, T., Schlabach, P., Schmidt, E. E., Schmidt, M. P., Schmitt, M., Schwarz, T., Scodellaro, L., Scott, A. L., Scribano, A., Scuri, F., Sedov, A., Seidel, S., Seiya, Y., Semenov, A., Sexton-Kennedy, L., Sfyrla, A., Shalhout, S. Z., Shapiro, M. D., Shears, T., Shepard, P. F., Sherman, D., Shimojima, M., Shochet, M., Shon, Y., Shreyber, I., Sidoti, A., Sinervo, P., Sisakyan, A., Slaughter, A. J., Slaunwhite, J., Sliwa, K., Smith, J. R., Snider, F. D., Snihur, R., Soderberg, M., Soha, A., Somalwar, S., Sorin, V., Spalding, J., Spinella, F., Spreitzer, T., Squillacioti, P., Stanitzki, M., Staveris-Polykalas, A., t. Denis R., S, Stelzer, B., Stelzer-Chilton, O., Stentz, D., Strologas, J., Stuart, D., Suh, J. S., Sukhanov, A., Sun, H., Suslov, I., Suzuki, T., Taffard, A., Takashima, R., Takeuchi, Y., Tanaka, R., Tecchio, M., Teng, P. K., Terashi, K., Thom, J., Thompson, A. S., Thomson, E., Tipton, P., Tiwari, V., Tkaczyk, S., Toback, D., Tokar, S., Tollefson, K., Tomura, T., Tonelli, D., Torre, S., Torretta, D., Tourneur, S., Trischuk, W., Tsuno, S., Tu, Y., Turini, N., Ukegawa, F., Uozumi, S., Vallecorsa, S., Van Remortel, N., Varganov, A., Vataga, E., Vazquez, F., Velev, G., Vellidis, C., Veramendi, G., Veszpremi, V., Vidal, M., Vidal, R., Vila, I., Vilar, R., Vine, T., Vogel, M., Vollrath, I., Volobouev, I., Volpi, G., Würthwein, F., Wagner, P., Wagner, R. G., Wagner, R. L., Wagner, J., Wagner, W., Wallny, R., Wang, S. M., Warburton, A., Waters, D., Weinberger, M., Wester, W. C., Whitehouse, B., Whiteson, D., Wicklund, A. B., Wicklund, E., Williams, G., Williams, H. H., Wilson, P., Winer, B. L., Wittich, P., Wolbers, S., Wolfe, C., Wright, T., Wu, X., Wynne, S. M., Yagil, A., Yamamoto, K., Yamaoka, J., Yamashita, T., Yang, C., Yang, U. K., Yang, Y. C., Yao, W. M., Yeh, G. P., Yoh, J., Yorita, K., Yoshida, T., G. B., Yu, Yu, I., S. S., Yu, Yun, J. C., Zanello, L., Zanetti, A., Zaw, I., Zhang, X., Zhou, J., Zucchelli, S., Aaltonen, T, Abulencia, A, Adelman, J, Affolder, T, Akimoto, T, Albrow, Mg, Amerio, S, Amidei, D, Anastassov, A, Anikeev, K, Annovi, A, Antos, J, Aoki, M, Apollinari, G, Arisawa, T, Artikov, A, Ashmanskas, W, Attal, A, Aurisano, A, Azfar, F, Azzi Bacchetta, P, Azzurri, P, Bacchetta, N, Badgett, W, Barbaro Galtieri, A, Barnes, Ve, Barnett, Ba, Baroiant, S, Bartsch, V, Bauer, G, Beauchemin, Ph, Bedeschi, F, Behari, S, Bellettini, G, Bellinger, J, Belloni, A, Benjamin, D, Beretvas, A, Beringer, J, Berry, T, Bhatti, A, Binkley, M, Bisello, D, Bizjak, I, Blair, Re, Blocker, C, Blumenfeld, B, Bocci, A, Bodek, A, Boisvert, V, Bolla, G, Bolshov, A, Bortoletto, D, Boudreau, J, Boveia, A, Brau, B, Brigliadori, L, Bromberg, C, Brubaker, E, Budagov, J, Budd, H, Budd, S, Burkett, K, Busetto, G, Bussey, P, Buzatu, A, Byrum, Kl, Cabrera, S, Campanelli, M, Campbell, M, Canelli, F, Canepa, A, Carrillo, S, Carlsmith, D, Carosi, R, Carron, S, Casal, B, Casarsa, M, Castro, A, Catastini, P, Cauz, D, Cavalli Sforza, M, Cerri, A, Cerrito, L, Chang, Sh, Chen, Yc, Chertok, M, Chiarelli, G, Chlachidze, G, Chlebana, F, Cho, I, Cho, K, Chokheli, D, Chou, Jp, Choudalakis, G, Chuang, Sh, Chung, K, Chung, Wh, Chung, Y, Cilijak, M, Ciobanu, Ci, Ciocci, Ma, Clark, A, Clark, D, Coca, M, Compostella, G, Convery, Me, Conway, J, Cooper, B, Copic, K, Cordelli, M, Cortiana, G, Crescioli, F, Almenar, Cc, Cuevas, J, Culbertson, R, Cully, Jc, Daronco, S, Datta, M, D'Auria, S, Davies, T, Dagenhart, D, de Barbaro, P, De Cecco, S, Deisher, A, De Lentdecker, G, De Lorenzo, G, Dell'Orso, M, Delli Paoli, F, Demortier, L, Deng, J, Deninno, M, De Pedis, D, Derwent, Pf, Di Giovanni, Gp, Dionisi, C, Di Ruzza, B, Dittmann, Jr, D'Onofrio, M, Dorr, C, Donati, S, Dong, P, Donini, J, Dorigo, T, Dube, S, Efron, J, Erbacher, R, Errede, D, Errede, S, Eusebi, R, Fang, Hc, Farrington, S, Fedorko, I, Fedorko, Wt, Feild, Rg, Feindt, M, Fernandez, Jp, Field, R, Flanagan, G, Forrest, R, Forrester, S, Franklin, M, Freeman, Jc, Furic, I, Gallinaro, M, Galyardt, J, Garcia, Je, Garberson, F, Garfinkel, Af, Gay, C, Gerberich, H, Gerdes, D, Giagu, S, Giannetti, P, Gibson, K, Gimmell, Jl, Ginsburg, C, Giokaris, N, Giordani, M, Giromini, P, Giunta, M, Giurgiu, G, Glagolev, V, Glenzinski, D, Gold, M, Goldschmidt, N, Goldstein, J, Golossanov, A, Gomez, G, Gomez Ceballos, G, Goncharov, M, Gonzalez, O, Gorelov, I, Goshaw, At, Goulianos, K, Gresele, A, Grinstein, S, Grosso Pilcher, C, Group, Rc, Grundler, U, Guimaraes da Costa, J, Gunay Unalan, Z, Haber, C, Hahn, K, Hahn, Sr, Halkiadakis, E, Hamilton, A, Han, By, Han, Jy, Handler, R, Happacher, F, Hara, K, Hare, D, Hare, M, Harper, S, Harr, Rf, Harris, Rm, Hartz, M, Hatakeyama, K, Hauser, J, Hays, C, Heck, M, Heijboer, A, Heinemann, B, Heinrich, J, Henderson, C, Herndon, M, Heuser, J, Hidas, D, Hill, C, Hirschbuehl, D, Hocker, A, Holloway, A, Hou, S, Houlden, M, Hsu, Sc, Huffman, Bt, Hughes, Re, Husemann, U, Huston, J, Incandela, J, Introzzi, G, Iori, M, Ivanov, A, Iyutin, B, James, E, Jang, D, Jayatilaka, B, Jeans, D, Jeon, Ej, Jindariani, S, Johnson, W, Jones, M, Joo, Kk, Jun, Sy, Jung, Je, Junk, Tr, Kamon, T, Karchin, Pe, Kato, Y, Kemp, Y, Kephart, R, Kerzel, U, Khotilovich, V, Kilminster, B, Kim, Dh, Kim, H, Kim, Je, Kim, Mj, Kim, Sb, Kim, Sh, Kim, Yk, Kimura, N, Kirsch, L, Klimenko, S, Klute, M, Knuteson, B, Ko, Br, Kondo, K, Kong, Dj, Konigsberg, J, Korytov, A, Kotwal, Av, Kraan, Ac, Kraus, J, Kreps, M, Kroll, J, Krumnack, N, Kruse, M, Krutelyov, V, Kubo, T, Kuhlmann, Se, Kuhr, T, Kulkarni, Np, Kusakabe, Y, Kwang, S, Laasanen, At, Lai, S, Lami, S, Lammel, S, Lancaster, M, Lander, Rl, Lannon, K, Lath, A, Latino, G, Lazzizzera, I, Lecompte, T, Lee, J, Lee, Yj, Lee, Sw, Lefevre, R, Leonardo, N, Leono, S, Levy, S, Lewis, Jd, Lin, C, Lindgren, M, Lipeles, E, Lister, A, Litvintsev, Do, Liu, T, Lockyer, N, Loginov, A, Loreti, M, Lu, R, Lucchesi, D, Lujan, P, Lukens, P, Lungu, G, Lyons, L, Lys, J, Lysak, R, Lytken, E, Mack, P, Mac Queen, D, Madrak, R, Maeshima, K, Makhoul, K, Maki, T, Maksimovic, P, Malde, S, Malik, S, Manca, G, Manousakis, A, Margaroli, F, Marginean, R, Marino, C, Marino, Cp, Martin, A, Martin, M, Martin, V, Martinez, M, Martinez Ballarin, R, Maruyama, T, Mastrandrea, P, Masubuchi, T, Matsunaga, H, Mattson, Me, Mazini, R, Mazzanti, P, Mcfarland, K, Mcintyre, P, Mcnulty, R, Mehta, A, Mehtala, P, Menzemer, S, Menzione, A, Merkel, P, Mesropian, C, Messina, A, Miao, T, Miladinovic, N, Miles, J, Miller, R, Mills, C, Milnik, M, Mitra, A, Mitselmakher, G, Miyamoto, A, Moed, S, Moggi, N, Mohr, B, Moon, C, Moore, R, Morello, M, Movilla Fernandez, P, Mulmenstadt, J, Mukherjee, A, Muller, T, Mumford, R, Murat, P, Mussini, M, Nachtman, J, Nagano, A, Naganoma, J, Nakamura, K, Nakano, I, Napier, A, Necula, V, Neu, C, Neubauer, M, Nielsen, J, Nodulman, L, Norniella, O, Nurse, E, Oh, Sh, Oh, Yd, Oksuzian, I, Okusawa, T, Oldeman, R, Orava, R, Osterberg, K, Pagliarone, C, Palencia, E, Papadimitriou, V, Papaikonomou, A, Paramonov, Aa, Parks, S, Pashapour, S, Patrick, J, Pauletta, G, Paulini, M, Paus, C, Pellett, De, Penzo, A, Phillips, Tj, Piacentino, G, Piedra, J, Pinera, L, Pitts, K, Plager, C, Pondrom, L, Portell, X, Poukhov, O, Pounder, N, Prakoshyn, F, Pronko, A, Proudfoot, J, Ptohos, F, Punzi, G, Pursley, J, Rademacker, J, Rahaman, A, Ramakrishnan, V, Ranjan, N, Redondo, I, Reisert, B, Rekovic, V, Renton, P, Rescigno, M, Richter, S, Rimondi, F, Ristori, L, Robson, A, Rodrigo, T, Rogers, E, Rolli, S, Roser, R, Rossi, M, Roy, P, Ruiz, A, Russ, J, Rusu, V, Saarikko, H, Safonov, A, Sakumoto, Wk, Salamanna, Giuseppe, Salto, O, Santi, L, Sarkar, S, Sartori, L, Sato, K, Savard, P, Savoy Navarro, A, Scheidel, T, Schlabach, P, Schmidt, Ee, Schmidt, Mp, Schmitt, M, Schwarz, T, Scodellaro, L, Scott, Al, Scribano, A, Scuri, F, Sedov, A, Seidel, S, Seiya, Y, Semenov, A, Sexton Kennedy, L, Sfyrla, A, Shalhout, Sz, Shapiro, Md, Shears, T, Shepard, Pf, Sherman, D, Shimojima, M, Shochet, M, Shon, Y, Shreyber, I, Sidoti, A, Sinervo, P, Sisakyan, A, Slaughter, Aj, Slaunwhite, J, Sliwa, K, Smith, Jr, Snider, Fd, Snihur, R, Soderberg, M, Soha, A, Somalwar, S, Sorin, V, Spalding, J, Spinella, F, Spreitzer, T, Squillacioti, P, Stanitzki, M, Staveris Polykalas, A, St Dennis, R, Stelzer, B, Stelzer Chilton, O, Stentz, D, Strologas, J, Stuart, D, Suh, J, Sukhanov, A, Sun, H, Suslov, I, Suzuki, T, Taffard, A, Takashima, R, Takeuchi, Y, Tanaka, R, Tecchio, M, Teng, Pk, Terashi, K, Thom, J, Thompson, A, Thomson, E, Tipton, P, Tiwari, V, Tkaczyk, S, Toback, D, Tokar, S, Tollefson, K, Tomura, T, Tonelli, D, Torre, S, Torretta, D, Tourneur, S, Trischuk, W, Tsuno, S, Tu, Y, Turini, N, Ukegawa, F, Uozumi, S, Vallecorsa, S, van Remortel, N, Varganov, A, Vataga, E, Vazquez, F, Velev, G, Vellidis, C, Veramendi, G, Veszpremi, V, Vidal, M, Vidal, R, Vila, I, Vilar, R, Vine, T, Vogel, M, Vollrath, I, Volobouev, I, Volpi, G, Wurthwein, F, Wagner, P, Wagner, Rg, Wagner, Rl, Wagner, J, Wagner, W, Wallny, R, Wang, Sm, Warburton, A, Waters, D, Weinberger, M, Wester, Wc, Whitehouse, B, Whiteson, D, Wicklund, Ab, Williams, G, Williams, Hh, Wilson, P, Winer, Bl, Wittich, P, Wolbers, S, Wolfe, C, Wright, T, Wu, X, Wynne, Sm, Yagil, A, Yamamoto, K, Yamaoka, J, Yamashita, T, Yang, C, Yang, Uk, Yang, Yc, Yao, Wm, Yeh, Gp, Yoh, J, Yorita, K, Yoshida, T, Yu, Gb, Yu, I, Yu, S, Yun, Jc, Zanello, L, Zanetti, A, Zaw, I, Zhang, X, Zhou, J, Zucchelli, S, and Wicklund, E.
- Published
- 2007
223. The use of gated radionuclide angiography in the diagnosis of cardiac contusion
- Author
-
Parks, S
- Published
- 1984
- Full Text
- View/download PDF
224. NMR IN PARAMAGNETIC NdBr$sub 3$ AND UI$sub 3$ AND IN ANTIFERROMAGNETIC UI .
- Author
-
Parks, S
- Published
- 1967
225. 359 - Dissecting the pro-tumoural role of the essential amino-acid transporter complex CD98/LAT1.
- Author
-
Cormerais, Y., Giuliano, S., Massard, P.A., Durivault, J., Hitoshi, E., Michael, W., Parks, S., and Pouyssegur, J.
- Published
- 2016
- Full Text
- View/download PDF
226. Hydrostatic pressure response of an oxide-based two-dimensional electron system.
- Author
-
Zabaleta, J., Borisov, V. S., Wanke, R., Jeschke, H. O., Parks, S. C., Baum, B., Teker, A., Harada, T., Syassen, K., Kopp, T., Pavlenko, N., Valentí, R., and Mannhart, J.
- Subjects
- *
HYDROSTATIC pressure , *SEMICONDUCTORS , *ELECTRON gas - Abstract
Two-dimensional electron systems with fascinating properties exist in multilayers of standard semiconductors, on helium surfaces, and in oxides. Compared to the two-dimensional (2D) electron gases of semiconductors, the 2D electron systems in oxides are typically more strongly correlated and more sensitive to the microscopic structure of the hosting lattice. This sensitivity suggests that the oxide 2D systems are highly tunable by hydrostatic pressure. Here we explore the effects of hydrostatic pressure on the well-characterized 2D electron system formed at LaAlO3-SrTiO3 interfaces [A. Ohtomo and H. Y. Hwang, Nature (London) 427, 423 (2004)] and measure a pronounced, unexpected response. Pressure of ~2 GPa reversibly doubles the 2D carrier density ns at 4 K. Along with the increase of ns, the conductivity and mobility are reduced under pressure. First-principles pressure simulations reveal the same behavior of the carrier density and suggest a possible mechanism of the mobility reduction, based on the dielectric properties of both materials and their variation under external pressure. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
227. Development of high-senstivity ultrasonic techniques for in-service inspection of nuclear reactors. Annual report, October 1, 1976--September 30, 1977
- Author
-
Parks, S
- Published
- 1978
228. Development of high-sensitivity ultrasonic techniques for in-service inspection of nuclear reactors. Annual report, 1 October 1976--30 September 1977
- Author
-
Parks, S
- Published
- 1978
229. EFFECTS OF PLASTICIZERS ON RESISTANCE OF POLYVINYL CHLORIDE TO GAMMA IRRADIATION
- Author
-
Parks, S
- Published
- 1958
230. Multi-run chemical cutter and method
- Author
-
Parks, S
- Published
- 1989
231. Delivering an innovative multi-infection and female genital mutilation screening to high-risk migrant populations (ISMiHealth): study protocol of a cluster randomised controlled trial with embedded process evaluation.
- Author
-
Cruz A, Cuxart-Graell A, Gonçalves AQ, Vázquez-Villegas J, Vallejo-Godoy S, Salas-Coronas J, Piqueras N, Martínez-Torres S, Artigues-Barberà E, Rando-Matos Y, Margalejo AA, Vizcaíno J, Requena P, Martínez-Pérez Á, Ferrer E, Méndez-Boo L, Coma E, Luzón-García MP, Sequeira-Aymar E, Casellas A, Vázquez M, Jacques-Aviñó C, Medina-Perucha L, Sicuri E, Evangelidou S, Aguilar Martín C, and Requena-Mendez A
- Subjects
- Humans, Female, Spain, Mass Screening methods, Primary Health Care, Randomized Controlled Trials as Topic, Decision Support Systems, Clinical, Communicable Diseases diagnosis, Circumcision, Female, Transients and Migrants
- Abstract
Introduction: ISMiHealth is a clinical decision support system, integrated as a software tool in the electronic health record system of primary care, that aims to improve the screening performance on infectious diseases and female genital mutilation (FGM) in migrants. The aim of this study is to assess the health impact of the tool and to perform a process evaluation of its feasibility and acceptability when implemented in primary care in Catalonia (Spain)., Methods and Analysis: This study is a cluster randomised control trial where 35 primary care centres in Catalonia, Spain will be allocated into one of the two groups: intervention and control. The health professionals in the intervention centres will receive prompts, through the ISMiHealth software, with screening recommendations for infectious diseases and FGM targeting the migrant population based on an individualised risk assessment. Health professionals of the control centres will follow the current routine practice.A difference in differences analysis of the diagnostic rates for all aggregated infections and each individual condition between the intervention and control centres will be performed. Mixed-effects logistic regression models will be carried out to identify associations between the screening coverage and predictor factors. In addition, a process evaluation will be carried out using mixed methodology., Ethics and Dissemination: The study protocol has been approved by the institutional review boards at Hospital Clínic (16 June 2022, HCB/2022/0363), Clinical Research Ethics Committee of the Primary Care Research Institute IDIAPJGol (22 June 2022, 22/113-P) and the Almería Research Ethics Committee (27 July 2022, EMC/apg). The study will follow the tenets of the Declaration of Helsinki and Good Clinical Practice. All researchers and associates signed a collaboration agreement in which they undertake to abide by good clinical practice standards.Findings will be disseminated in peer-reviewed journals and communications to congresses., Trial Registration Number: NCT05868005., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
232. (Re)assessing Clinical Spaces: How do we Critically Provide Mental Health and Disability Support and Effective Care for Black and Brown Young People who are Impacted by Structural Violence and Structural Racism?
- Author
-
Irsheid SB, Keeney Parks S, and Lindsey MA
- Subjects
- Adolescent, Child, Female, Humans, Male, Disabled Persons psychology, Racism, Violence, Minority Groups psychology, Black or African American psychology, Mental Health Services, Systemic Racism
- Abstract
We open this article by asking you to consider that the magnitude of racism present in clinical spaces is much larger and more in depth than we can ever begin to cover. In this spirit, we are going to provide you with some context to think about the problem of racism and mental health and disability and ways to deconstruct the problem through the lens of structural violence and structural racism. We offer you a brief discussion on and a definition of structural violence and structural racism and then tie them to two case studies to help contextualize how racism currently exists within the medical field. We hope that the language and framework of structural violence and structural racism will help you think anew about racism and your own interactions with it. Although the difficulties with racial and structural violence are much too pervasive and will take collective action to dismantle, we do think that giving a framework to think and talk about racism may help the ways that you choose to interact with your patients, engage in clinical assessments, diagnosis, treatment, and navigate systems from your current role within the medical field., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
233. Enhancing Prehospital Care During the Conflict in Ukraine: NATO's Role in Global Health Engagement.
- Author
-
Onderková A, Quinn J, Meoli M, Taylor D, Nesterenko S, Schramm JM, Gimpelson AJ, O'Kelly A, Parks S, Rizek J, Davis T, Surkov D, Cherniawski B, and Fernando R
- Abstract
Introduction: The conflict in Ukraine, ongoing since 2014 and escalating with the Russian invasion in 2022, has unveiled profound challenges in prehospital care essential for the survival and recovery of warfighters and civilians alike, necessitating a detailed examination of the current medical response mechanisms and their effectiveness., Materials and Methods: This study provides an overview of these challenges and examines how these critical vulnerabilities have impacted the delivery of medical care in war-torn regions. It also explores the role of NATO and its member states in addressing these challenges, focusing on the efforts to standardize prehospital care, enhance training, and foster interoperability among medical services. Furthermore, it explores the role of global heath engagement through NGOs in addressing these prehospital care gaps within the Ukrainian conflict zone, drawing from direct observations, expert testimonials, and secondary data., Results: Findings reveal significant enhancements in prehospital care through improved training, interoperability, and logistics management, despite ongoing challenges in medical infrastructure and extended evacuation times, which continue to impact the quality of care., Conclusions: The study underscores the critical role of international collaboration and standardized protocols in bolstering prehospital medical responses in conflict settings, highlighting the need for continuous adaptation and support to mitigate the complexities of modern warfare. The insights gained from the Ukraine conflict offer valuable lessons for future military and humanitarian medical responses in similar conflict settings., (© The Association of Military Surgeons of the United States 2024. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site–for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
234. Understanding three approaches to reporting sudden unexpected infant death in the USA.
- Author
-
Erck Lambert AB, Parks S, Bergman K, Cottengim C, Woster A, Shaw E, Ma H, Heitmann R, Riehle-Colarusso T, and Shapiro-Mendoza C
- Subjects
- Humans, Infant, United States epidemiology, Infant, Newborn, International Classification of Diseases, Registries, Male, Female, Population Surveillance, Sudden Infant Death epidemiology, Cause of Death
- Abstract
Introduction: In the USA each year, there are approximately 3400 sudden unexpected infant (<1 year of age) deaths (SUID) which occur without an obvious cause before an investigation. SUID includes the causes of death (COD) undetermined/unknown, sleep-related suffocation/asphyxia and sudden infant death syndrome (SIDS); these are often called SUID subtypes. Three common ways SUID subtypes are grouped (SUID subtype groups) include International Classification of Diseases (ICD) Codes, SUID Case Registry Categories or Child Death Review (CDR)-Assigned Causes. These groups are often used to monitor SUID trends and characteristics at the local, state and national levels. We describe and compare the characteristics of these three SUID subtype groups., Discussion: SUID subtype groups are distinct and not directly interchangeable. They vary in purpose, strengths, limitations, uses, history, data years available, population coverage, assigning entity, guidance documentation and information available to assign subtypes., Conclusion: Making informed decisions about which SUID subtype group to use is important for reporting statistics, increasing knowledge of SUID epidemiology and informing prevention strategies., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
235. Erythrophagocytosis by dysplastic neutrophils and their precursors.
- Author
-
Zhao Y, Parks S, Siddiqi I, and Wang E
- Subjects
- Humans, Male, Erythrocytes pathology, Erythrocytes metabolism, Female, Neutrophils pathology, Phagocytosis
- Published
- 2024
- Full Text
- View/download PDF
236. Fellowship-trained physicians who let their geriatric medicine certification lapse: A national survey.
- Author
-
Ross K, Lynn L, Foley KT, Barczi SR, Widera E, Parks S, Luz C, Colburn JL, and Leff B
- Subjects
- Aged, Humans, United States, Fellowships and Scholarships, Medicare, Certification, Physicians, Geriatrics
- Abstract
Background: Only 62.6% of fellowship-trained and American Board of Internal Medicine (ABIM)-certified geriatricians maintain their specialty certification in geriatric medicine, the lowest rate among all internal medicine subspecialties and the only subspecialty in which physicians maintain their internal medicine certification at higher rates than their specialty certification. This study aims to better understand underlying issues related to the low rate of maintaining geriatric medicine certification in order to inform geriatric workforce development strategies., Methods: Eighteen-item online survey of internists who completed a geriatric medicine fellowship, earned initial ABIM certification in geriatric medicine between 1999 and 2009, and maintained certification in internal medicine (and/or another specialty but not geriatric medicine). Survey domains: demographics, issues related to maintaining geriatric medicine certification, professional identity, and current professional duties., Results: 153/723 eligible completed surveys (21.5% response). Top reasons for not maintaining geriatric medicine certification were time (56%), cost of maintenance of certification (MOC) (45%), low Medicare reimbursement for geriatricians' work (32%), and no employer requirement to maintain geriatric medicine certification (31%). Though not maintaining geriatric medicine certification, 68% reported engaging in professional activities related to geriatric medicine. Reflecting on career decisions, 56% would again complete geriatric medicine fellowship, 21% would not, and 23% were unsure. 54% considered recertifying in geriatric medicine. 49% reported flexible MOC assessment options would increase likelihood of maintaining certification., Conclusions: The value proposition of geriatric medicine certification needs strengthening. Geriatric medicine leaders must develop strategies and tactics to reduce attrition of geriatricians by enhancing the value of geriatric medicine expertise to key stakeholders., (© 2024 The American Geriatrics Society.)
- Published
- 2024
- Full Text
- View/download PDF
237. Myelokathexis in an 18-year-old male patient with severe neutropenia and lymphopenia.
- Author
-
Wang E, Zhao Y, Parks S, and Siddiqi I
- Subjects
- Male, Humans, Adolescent, Neutropenia, Lymphopenia complications, Bone Marrow Diseases
- Published
- 2024
- Full Text
- View/download PDF
238. Collusions of Fact and Fiction : Performing Slavery in the Works of Suzan-Lori Parks and Kara Walker
- Author
-
PARKS, SUZAN-LORI, WALKER, KARA, PARKS, SUZAN-LORI, and WALKER, KARA
- Published
- 2021
- Full Text
- View/download PDF
239. Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney Transplant.
- Author
-
Huck DM, Weber B, Schreiber B, Pandav J, Parks S, Hainer J, Brown JM, Divakaran S, Blankstein R, Dorbala S, Trinquart L, Chandraker A, and Di Carli MF
- Subjects
- Humans, Male, Middle Aged, Female, Prospective Studies, Retrospective Studies, Tomography, Emission-Computed, Single-Photon methods, Positron-Emission Tomography, Prognosis, Kidney Transplantation adverse effects, Myocardial Perfusion Imaging methods, Coronary Artery Disease
- Abstract
Background: Advanced chronic kidney disease is associated with high cardiovascular risk, even after kidney transplant. Pretransplant cardiac testing may identify patients who require additional assessment before transplant or would benefit from risk optimization. The objective of the current study was to determine the relative prognostic utility of pretransplant positron emission tomography (PET) and single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for posttransplant major adverse cardiovascular events (MACEs)., Methods: We retrospectively followed patients who underwent MPI before kidney transplant for the occurrence of MACE after transplant including myocardial infarction, stroke, heart failure, and cardiac death. An abnormal MPI result was defined as a total perfusion deficit >5% of the myocardium. To determine associations of MPI results with MACE, we utilized Cox hazard regression with propensity weighting for PET versus SPECT with model factors, including demographics and cardiovascular risk factors., Results: A total of 393 patients underwent MPI (208 PET and 185 SPECT) and were followed for a median of 5.9 years post-transplant. Most were male (58%), median age was 58 years, and there was a high burden of hypertension (88%) and diabetes (33%). A minority had abnormal MPI (n=58, 15%). In propensity-weighted hazard regression, abnormal PET result was associated with posttransplant MACE (hazard ratio, 3.02 [95% CI, 1.78-5.11]; P <0.001), while there was insufficient evidence of an association of abnormal SPECT result with MACE (1.39 [95% CI, 0.72-2.66]; P =0.33). The explained relative risk of the PET result was higher than the SPECT result (R
2 0.086 versus 0.007). Normal PET was associated with the lowest risk of MACE (2.2%/year versus 3.6%/year for normal SPECT; P <0.001)., Conclusions: Kidney transplant recipients are at high cardiovascular risk, despite a minority having obstructive coronary artery disease on MPI. PET MPI findings predict posttransplant MACE. Normal PET may better discriminate lower risk patients compared with normal SPECT, which should be confirmed in a larger prospective study., Competing Interests: Disclosures Dr Weber reports consulting/scientific advisory board fees from Novo Nordisk, Kiniksa Pharmaceuticals, and Horizon Therapeutics. Dr Brown received consulting fees from Bayer, unrelated to the current work. Dr Divakaran received consulting fees from Kinevant Sciences, unrelated to the current work. Dr Blankstein reports research support and consulting from Amgen, Novartis, and Beren Therapeutics. Dr Dorbala reports personal consulting fees from GE HealthCare. Dr Chandraker reports grants from Bristol Myers Squibb, ViroPharma, Inc, IQVIA RDS, Inc, CSL Behring, LLC, Natera, Inc, Amgen, Inc, Hansa Biopharma AB, Sanofi US Services, Inc, and AlloVir, Inc, and personal consulting fees from AlloVir, Inc, eGenesis, Immucor, Natera, Inc, and Shire. Dr Di Carli received institutional research funding from Gilead Sciences, in-kind support from Amgen, and consulting fees from MedTrace and Sanofi. The other authors report no conflicts.- Published
- 2024
- Full Text
- View/download PDF
240. Reducing Cancer Cell Adhesion using Microtextured Surfaces.
- Author
-
McCue C, Atari A, Parks S, Tseng YY, and Varanasi KK
- Subjects
- Cell Adhesion, Cells, Cultured, Physical Phenomena, Cell Culture Techniques, Neoplasms
- Abstract
For the past century, trypsin has been the primary method of cell dissociation, largely without any major changes to the process. Enzymatic cell detachment strategies for large-scale cell culturing processes are popular but can be labor-intensive, potentially lead to the accumulation of genetic mutations, and produce large quantities of liquid waste. Therefore, engineering surfaces to lower cell adhesion strength could enable the next generation of cell culture surfaces for delicate primary cells and automated, high-throughput workflows. In this study, a process for creating microtextured polystyrene (PS) surfaces to measure the impact of microposts on the adhesion strength of cells is developed. Cell viability and proliferation assays show comparable results in two cancer cell lines between micropost surfaces and standard cell culture vessels. However, cell image analysis on microposts reveals that cell area decreases by half, and leads to an average twofold increase in cell length per area. Using a microfluidic-based method up to a seven times greater percentage of cells are removed from micropost surfaces than the flat control surfaces. These results show that micropost surfaces enable decreased cell adhesion strength while maintaining similar cell viabilities and proliferation as compared to flat PS surfaces., (© 2023 The Authors. Small published by Wiley-VCH GmbH.)
- Published
- 2023
- Full Text
- View/download PDF
241. Coronary Microcirculatory Dysfunction in People With HIV and Its Association With Antiretroviral Therapy.
- Author
-
Huck DM, Weber B, Parks S, Divakaran S, Brown JM, Bibbo CF, Barrett L, Hainer J, Bay C, Martell L, Kogelman L, Triant VA, Chu J, Lin NH, Melbourne K, Sax PE, and Di Carli MF
- Subjects
- Humans, Male, Middle Aged, Female, Cross-Sectional Studies, Emtricitabine therapeutic use, Coronary Circulation drug effects, Anti-HIV Agents therapeutic use, Anti-HIV Agents adverse effects, Lamivudine therapeutic use, Adult, Positron-Emission Tomography, Case-Control Studies, Alanine therapeutic use, Myocardial Perfusion Imaging methods, Drug Substitution, Aged, Coronary Vessels physiopathology, Coronary Vessels diagnostic imaging, Coronary Vessels drug effects, Cyclopropanes, Drug Combinations, Dideoxyadenosine analogs & derivatives, HIV Infections drug therapy, HIV Infections physiopathology, Microcirculation drug effects, Pyridones therapeutic use, Oxazines therapeutic use, Heterocyclic Compounds, 3-Ring therapeutic use, Heterocyclic Compounds, 3-Ring adverse effects, Dideoxynucleosides therapeutic use, Tenofovir therapeutic use, Piperazines therapeutic use
- Abstract
Background: HIV infection and abacavir-containing antiretroviral regimens are associated with vascular endothelial dysfunction and increased cardiovascular risk. Positron emission tomography (PET)-derived myocardial blood flow reserve (MBFR), the ratio of vasodilator stress to rest myocardial blood flow, is a well-validated measure of coronary microvascular health and marker of cardiovascular risk. Our objective was to compare MBFR among people with HIV (PWH) with matched non-HIV controls and to assess whether switching from dolutegravir/lamivudine/abacavir to the non-abacavir regimen bictegravir/emtricitabine/tenofovir alafenamide (TAF) would improve MBFR., Methods and Results: Thirty-seven PWH were 1:2 matched on cardiovascular risk factors to 75 people without HIV, and MBFR corrected for differences in resting hemodynamics was compared in a cross-sectional design. PWH were majority men (68%) with a mean age of 56 years. Mean stress myocardial blood flow (1.83 mL/min per g [95% CI, 1.68-1.98] versus 2.40 mL/min per g [95% CI, 2.25-2.54]; P <0.001) and MBFR (2.18 [95% CI, 1.96-2.40] versus 2.68 [95% CI, 2.47-2.89]; P =0.002) was significantly lower in PWH than in people without HIV. In a single-arm, multicenter trial, a subset of 25 PWH who were virologically suppressed on dolutegravir/lamivudine/abacavir underwent positron emission tomography myocardial perfusion imaging at baseline and after switching to bictegravir/emtricitabine/TAF. MBFR was unchanged after switching to bictegravir/emtricitabine/TAF for a mean of 27 weeks (MBFR, 2.34 to 2.29; P =0.61), except in PWH with impaired MBFR at baseline (<2.00; N=6) in whom MBFR increased from 1.58 to 2.02 ( P =0.02)., Conclusions: PWH had reduced coronary microvascular function compared with controls without HIV. Coronary microvascular function did not improve after switching from dolutegravir/lamivudine/abacavir to bictegravir/emtricitabine/TAF., Registration: URL: https://www.clinicaltrials.gov; unique identifier: NCT03656783.
- Published
- 2023
- Full Text
- View/download PDF
242. Feasibility of Simultaneous Quantification of Myocardial and Renal Perfusion With Cardiac Positron Emission Tomography.
- Author
-
Brown JM, Park MA, Kijewski MF, Weber BN, Yang Y, Martell L, Perillo A, Barrett L, Parks S, Hainer J, Dorbala S, Blankstein R, and Di Carli MF
- Subjects
- Humans, Feasibility Studies, Reproducibility of Results, Positron-Emission Tomography, Kidney diagnostic imaging, Perfusion, Fibrosis, Positron Emission Tomography Computed Tomography, Ammonia
- Abstract
Background: Given the central importance of cardiorenal interactions, mechanistic tools for evaluating cardiorenal physiology are needed. In the heart and kidneys, shared pathways of neurohormonal activation, hypertension, and vascular and interstitial fibrosis implicate the relevance of systemic vascular health. The availability of a long axial field of view positron emission tomography (PET)/computed tomography (CT) system enables simultaneous evaluation of cardiac and renal blood flow., Methods: This study evaluated the feasibility of quantification of renal blood flow using data acquired during routine, clinically indicated
13 N-ammonia myocardial perfusion PET/CT. Dynamic PET image data were used to calculate renal blood flow. Reproducibility was assessed by the intraclass correlation coefficient among 3 independent readers. PET-derived renal blood flow was correlated with imaging and clinical parameters in the overall cohort and with histopathology in a small companion study of patients with a native kidney biopsy., Results: Among 386 consecutive patients with myocardial perfusion PET/CT, 296 (76.7%) had evaluable images to quantify renal perfusion. PET quantification of renal blood flow was highly reproducible (intraclass correlation coefficient 0.98 [95% CI, 0.93-0.99]) and was correlated with the estimated glomerular filtration rate ( r =0.64; P <0.001). Compared across vascular beds, resting renal blood flow was correlated with maximal stress myocardial blood flow and myocardial flow reserve (stress/rest myocardial blood flow), an integrated marker of endothelial health. In patients with kidney biopsy (n=12), resting PET renal blood flow was strongly negatively correlated with histological interstitial fibrosis ( r =-0.85; P <0.001)., Conclusions: Renal blood flow can be reliably measured from cardiac13 N-ammonia PET/CT and allows for simultaneous assessment of myocardial and renal perfusion, opening a potential novel avenue to interrogate the mechanisms of emerging therapies with overlapping cardiac and renal benefits., Competing Interests: Disclosures Dr Brown reports consulting fees from Bayer. Dr Weber reports consulting fees from Horizon Therapeutics and Kiniksa Pharmaceuticals. Dr Dorbala reports unrelated grant support from Attralus, Pfizer, GE healthcare, and Phillips. Dr Blankstein reports research support from Amgen and Novartis and has consulted for Caristo Inc and Elucid Inc. Dr Di Carli reports grant support from Gilead Sciences, in-kind research support from Amgen, and consulting fees from MedTrace. The other authors report no conflicts.- Published
- 2023
- Full Text
- View/download PDF
243. Assessment of Pain Treatments in Disorders of Upper Limbs: A Qualitative Study Protocol Based on Patients' Experiences.
- Author
-
Karcz WM, Artigues-Barberà E, Ortega Bravo M, Pooler Perea A, Palacín Peruga JM, and Gimeno Pi I
- Abstract
Chronic musculoskeletal pain (CMP) is one of the most common symptoms of musculoskeletal disorders. Carpal tunnel syndrome (CTS) and subacromial syndrome (SAS) are the most prevalent musculoskeletal disorders of the upper limbs. By collecting the opinions of patients with CTS and SAS, we aim to identify variables that could be introduced in the follow-up of CMP, and to detect barriers and facilitators of its treatments to improve their acceptance. This qualitative study is being conducted in Lleida, Spain, and explores the experiences and feelings of patients, and their acceptance of the standard of care. It follows the consolidated criteria for reporting qualitative research (COREQ) through focus groups, addressing issues with rigor and representativeness. By collecting patients' opinions, we expect to obtain valuable information to complement the set of variables previously used by health professionals in the follow-up of CMP, and to understand treatment barriers and facilitators.
- Published
- 2023
- Full Text
- View/download PDF
244. Improving Blueberry Fruit Nutritional Quality through Physiological and Genetic Interventions: A Review of Current Research and Future Directions.
- Author
-
Krishna P, Pandey G, Thomas R, and Parks S
- Abstract
Blueberry, hailed as an antioxidant superfood, is the fruit of small shrubs in the genus Vaccinium (family Ericaceae). The fruits are a rich source of vitamins, minerals and antioxidants such as flavonoids and phenolic acids. The antioxidative and anti-inflammatory activities derived from the polyphenolic compounds, particularly from the abundantly present anthocyanin pigment, have been highlighted as the major contributing factor to the health-benefitting properties of blueberry. In recent years, blueberry cultivation under polytunnels has expanded, with plastic covers designed to offer protection of crop and fruit yield from suboptimal environmental conditions and birds. An important consideration is that the covers reduce photosynthetically active radiation (PAR) and filter out ultraviolet (UV) radiation that is critical for the fruit's bioactive composition. Blueberry fruits grown under covers have been reported to have reduced antioxidant capacity as compared to fruits from open fields. In addition to light, abiotic stresses such as salinity, water deficit, and low temperature trigger accumulation of antioxidants. We highlight in this review how interventions such as light-emitting diodes (LEDs), photo-selective films, and exposure of plants to mild stresses, alongside developing new varieties with desired traits, could be used to optimise the nutritional quality, particularly the content of polyphenols, of blueberry grown under covers.
- Published
- 2023
- Full Text
- View/download PDF
245. An Integrated Care Model to Support Adolescents With Diabetes-related Quality-of-life Concerns: An Intervention Study.
- Author
-
Versloot J, Saab H, Minotti SC, Ali A, Ma J, Reid RJ, Parks S, and Zenlea I
- Subjects
- Adolescent, Humans, Glycated Hemoglobin, Quality of Life, Surveys and Questionnaires, Delivery of Health Care, Integrated, Diabetes Mellitus, Type 1 therapy
- Abstract
Background: Our aim in this study was to determine whether participating in an integrated stepped care model for adolescents with type 1 diabetes (T1D) would lead to improvements in overall quality of life (QoL), diabetes-related quality of life (DRQoL) and glycated hemoglobin (A1C) levels compared with usual care., Methods: A nonrandomized, 2-group, pre/post, delayed-intervention design was used for this study. The Mind Youth Questionnaire (MY-Q) was used to assess QoL and DRQoL. Adolescents attending the diabetes clinic using the stepped care model formed the intervention group (n=77). These adolescents completed the MY-Q, and the identified concerns were discussed and addressed with them by their care team as part of the care model. Adolescents attending a pediatric diabetes clinic on another site completed the MY-Q as a comparison group (n=39), results were not shared with their care team, and they received the standard care., Results: There were 116 adolescents between 13 to 17 years of age, who completed the MY-Q on 2 occasions. Baseline data were obtained on the first occasion, and, on the second occasion, an average of 12 months later, there was a follow-up assessment. At follow-up, adolescents in the intervention group had a significantly higher overall QoL and reported significantly fewer concerns on DRQoL domains than those in the comparison group. Participation in the intervention group, however, did not lead to improvements in A1C., Conclusion: This study shows that implementing an integrated stepped care model within an interprofessional pediatric diabetes clinic can lead to the improvement of adolescents' overall QoL and DRQoL., (Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
246. Association Between Systemic Vasculitis and Coronary Microvascular Dysfunction in the Absence of Obstructive Coronary Artery Disease.
- Author
-
Weber B, Wallace ZS, Parks S, Cook C, Huck DM, Garshick M, Brown JM, Divakaran S, Hainer J, Dorbala S, Blankstein R, Liao KP, Aghayev A, Choi HK, and Di Carli M
- Subjects
- Humans, Coronary Angiography, Microcirculation, Coronary Circulation, Coronary Vessels diagnostic imaging, Coronary Artery Disease diagnostic imaging, Myocardial Ischemia, Systemic Vasculitis
- Published
- 2023
- Full Text
- View/download PDF
247. Principles of reproducible metabolite profiling of enriched lymphocytes in tumors and ascites from human ovarian cancer.
- Author
-
Kilgour MK, MacPherson S, Zacharias LG, LeBlanc J, Babinszky S, Kowalchuk G, Parks S, Sheldon RD, Jones RG, DeBerardinis RJ, Hamilton PT, Watson PH, and Lum JJ
- Subjects
- Humans, Female, Metabolomics methods, Tumor Microenvironment, Lymphocytes metabolism, Ascites pathology, Ovarian Neoplasms metabolism, Ovarian Neoplasms pathology
- Abstract
Identifying metabolites and delineating their immune-regulatory contribution in the tumor microenvironment is an area of intense study. Interrogating metabolites and metabolic networks among immune cell subsets and host cells from resected tissues and fluids of human patients presents a major challenge, owing to the specialized handling of samples for downstream metabolomics. To address this, we first outline the importance of collaborating with a biobank for coordinating and streamlining workflow for point of care, sample collection, processing and cryopreservation. After specimen collection, we describe our 60-min rapid bead-based cellular enrichment method that supports metabolite analysis between T cells and tumor cells by mass spectrometry. We also describe how the metabolic data can be complemented with metabolic profiling by flow cytometry. This protocol can serve as a foundation for interrogating the metabolism of cell subsets from primary human ovarian cancer., (© 2022. Springer Nature Limited.)
- Published
- 2022
- Full Text
- View/download PDF
248. 'Warburg effect' controls tumor growth, bacterial, viral infections and immunity - Genetic deconstruction and therapeutic perspectives.
- Author
-
Pouysségur J, Marchiq I, Parks SK, Durivault J, Ždralević M, and Vucetic M
- Subjects
- Animals, Humans, Monocarboxylic Acid Transporters genetics, Monocarboxylic Acid Transporters metabolism, Cell Line, Tumor, Lactic Acid metabolism, Lactic Acid pharmacology, Bacteria metabolism, Hypoxia, Symporters genetics, Symporters metabolism, Virus Diseases
- Abstract
The evolutionary pressure for life transitioning from extended periods of hypoxia to an increasingly oxygenated atmosphere initiated drastic selections for a variety of biochemical pathways supporting the robust life currently present on the planet. First, we discuss how fermentative glycolysis, a primitive metabolic pathway present at the emergence of life, is instrumental for the rapid growth of cancer, regenerating tissues, immune cells but also bacteria and viruses during infections. The 'Warburg effect', activated via Myc and HIF-1 in response to growth factors and hypoxia, is an essential metabolic and energetic pathway which satisfies nutritional and energetic demands required for rapid genome replication. Second, we present the key role of lactic acid, the end-product of fermentative glycolysis able to move across cell membranes in both directions via monocarboxylate transporting proteins (i.e., MCT1/4) contributing to cell-pH homeostasis but also to the complex immune response via acidosis of the tumor microenvironment. Importantly lactate is recycled in multiple organs as a major metabolic precursor of gluconeogenesis and energy source protecting cells and animals from harsh nutritional or oxygen restrictions. Third, we revisit the Warburg effect via CRISPR-Cas9 disruption of glucose-6-phosphate isomerase (GPI-KO) or lactate dehydrogenases (LDHA/B-DKO) in two aggressive tumors (melanoma B16-F10, human adenocarcinoma LS174T). Full suppression of lactic acid production reduces but does not suppress tumor growth due to reactivation of OXPHOS. In contrast, disruption of the lactic acid transporters MCT1/4 suppressed glycolysis, mTORC1, and tumor growth as a result of intracellular acidosis. Finally, we briefly discuss the current clinical developments of an MCT1 specific drug AZ3965, and the recent progress for a specific in vivo MCT4 inhibitor, two drugs of very high potential for future cancer clinical applications., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
249. Prior SARS-CoV-2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography.
- Author
-
Weber B, Parks S, Huck DM, Kim A, Bay C, Brown JM, Divakaran S, Hainer J, Bibbo C, Taqueti V, Dorbala S, Blankstein R, Woolley AE, and Di Carli MF
- Subjects
- Humans, Female, Coronary Circulation physiology, Ammonia pharmacology, SARS-CoV-2, Tomography, X-Ray Computed, Positron-Emission Tomography methods, Myocardial Perfusion Imaging methods, COVID-19 complications, COVID-19 diagnosis, Cardiomyopathies, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease epidemiology, Fractional Flow Reserve, Myocardial
- Abstract
Background Cardiovascular complications from COVID-19 contribute to its high morbidity and mortality. The effect of COVID-19 infection on the coronary vasculature is not known. The objective of this study was to investigate the prevalence of coronary vasomotor dysfunction identified by coronary flow reserve from cardiac positron emission tomography in patients with previous COVID-19 infection. Methods and Results All patients who had polymerase chain reaction-confirmed SARS-CoV-2 infection referred for myocardial stress perfusion positron emission tomography imaging at Brigham and Women's Hospital from April 2020 to July 2021 were compared with a matched control group without prior SARS-CoV-2 infection imaged in the same period. The main outcome was the prevalence of coronary vasomotor dysfunction. Myocardial perfusion and myocardial blood flow reserve were quantified using N13-ammonia positron emission tomography imaging. Thirty-four patients with prior COVID-19 were identified and compared with 103 matched controls. The median time from polymerase chain reaction-confirmed SARS-CoV-2 to cardiac positron emission tomography was 4.6 months (interquartile range,1.2-5.6 months). There were 16 out of 34 (47%) patients previously hospitalized for COVID-19 infection. Baseline cardiac risk factors were common, and 18 (53%) patients in the COVID-19 group had abnormal myocardial perfusion. Myocardial blood flow reserve was abnormal (<2) in 44.0% of the patients with COVID-19 compared with 11.7% of matched controls ( P <0.001). The mean myocardial blood flow reserve was 19.4% lower in patients with COVID-19 compared with control patients (2.00±0.45 versus 2.48±0.47, P <0.001). Conclusions Myocardial blood flow reserve was impaired in patients with prior COVID-19 infection compared with cardiovascular risk factor-matched controls, suggesting a relationship between SARS-CoV-2 infection and coronary vascular health. These data highlight the need to assess long-term consequences of COVID-19 on vascular health in future prospective studies.
- Published
- 2022
- Full Text
- View/download PDF
250. Facilitators of and Barriers to Adherence to Dietary Interventions Perceived by Women With Multiple Sclerosis and Their Support Persons.
- Author
-
Dean C, Parks S, Titcomb TJ, Arthofer A, Meirick P, Grogan N, Ehlinger MA, Bisht B, Fox SS, Daack-Hirsch S, Snetselaar LG, and Wahls TL
- Abstract
Background: People with multiple sclerosis (MS) frequently report implementing dietary strategies as part of their personal wellness programs; however, little is known about the perceived themes of healthy behavior change in people with MS., Methods: Semistructured one-on-one interviews were conducted with 20 women with MS enrolled in 2 different restrictive dietary intervention studies and their 18 self-identified support persons consisting of partners and adult children. Interviews were transcribed, coded, categorized, and then grouped into summative themes. The frequency of issues being mentioned as facilitators of or barriers to diet adherence was evaluated to identify possible differences in perceived experiences between women with MS and their support persons during the studies., Results: Five qualitative themes were identified: (1) personal motivation, (2) diet components, (3) time, (4) support, and (5) resource access. Major facilitators of dietary adherence were positive support from support persons and study staff, access to resources, symptom improvement, and personal motivation. Major barriers included the novelty of the study diet, lack of cooking skills, no change in or worsening of symptoms, lack of diet knowledge, and food preferences and temptations. Symptom severity was more frequently reported as a barrier to study diet adherence among participants with secondary progressive MS., Conclusions: Methods to enhance personal motivation and ensure positive support from support persons and study staff may improve study diet adherence. Due to the unique challenges faced by people with MS, future studies should tailor interventions to their unique MS cohort to increase diet adherence., Competing Interests: FINANCIAL DISCLOSURES: Dr Wahls personally follows and promotes the Wahls diet. She has equity interest in the following companies: Terry Wahls, LLC; TZ Press, LLC; The Wahls Institute, PLC; FBB Biomed, Inc; and the website http://www.terrywahls.com. She also owns the copyright to the books Minding My Mitochondria (2nd edition) and The Wahls Protocol, The Wahls Protocol Cooking for Life, and the trademarks The Wahls Protocol, Wahls diet, Wahls Paleo diet, and Wahls Paleo Plus diet (the Wahls elimination diet is not trademarked). She has completed grant funding from the National Multiple Sclerosis Society for the Dietary Approaches to Treating Multiple Sclerosis Related Fatigue Study. She has financial relationships with BioCeuticals; MCG Health, LLC; Genova Diagnostics; and the Institute for Functional Medicine. She receives royalty payments from Penguin Random House. She has conflict of interest management plans in place with the University of Iowa and the Iowa City VA Health Care System. The other authors have disclosed no relevant financial relationships., (© 2022 Consortium of Multiple Sclerosis Centers.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.